I can believe Biomm will submit by early June. But did not realize we are this far from trial. “Expected start date in June.” ANVISA has to approve a rather demanding protocol, after our FDA letter, and that within a couple of weeks. Who is confident of that happening? Every time there is some stop, the next go seems to happen in months time.
It may happen still if there is already behind the scene communication between Biomm and ANVISA and our protocol was finalized based on such communications, and these present PRs are more like routine to keep investors aware. That’s a lot of ifs to hope for; Nader has to explain.
News 
Market Data 
Discover 
